RE:RE:RE:RE:cxr price is too low , hostile takeover is imminent Just a friendly response
1) legacy pharma drugs command 5 times ebitda....the debt target is 6.4 IF everything goes well. That tells me the shares are essentially worth nothing let alone a premium. I'm unaware of any blockbuster drugs with patent protection in the Cxr portfolio.
2) MT makes $9 million a year. He can ride this out for a few years and probably live comfortably.
3) check the court dockets, you'll see some dates set and due to the press releases before the earnings blunder, write down, and revised guidance, they probably have teeth. This simply isn't ambulance chasers threatening because the price went down.
there are investigations of 4 un-named companies in the Uk. After the public expose in major Uk papers i would find it hard to believe they aren't one of them. Also in the US, Clinton is going to be setting up a committee to investigate companies who have raised prices by large amounts....may take some time, but the market is forward looking.
May also be unfair to compare to Vrx as they do have drugs and brands with moats around them. Its probably a sewer too, but i havent looked hard at it.
Register123 wrote: My take:
1) I think shareholders would be open to either a hostile or friendly takeover. It would likely be worthwhile for a company to try a hostile takeover if MT and the Board are resistant to one as I suspect many major shareholders have had it with managment and the Board.
2) I think it is in MT's best interest to accept a reasonable takeover offer.....He was forced to sell a large block of his shares to cover a margin call at what was likely around $12.00 per share (the news about this forced sale of CXR shares was released on August 22, 205 and the press release stated "...Concordia's Chairman and Chief Executive Officer Mark Thompson was notified earlier today of the sale of 505,000 of his shares as part of a margin call", and he stil owns over 1.5 million CXR shares......If, as an example, an offer by Carlyle or another firm was at say $25 Canadian, MT would be crazy not to take it.....how long will it take for CXR's share price to get back to $25, if ever....?......instead, he can take the money now at this hefty premium and move one.....
3) Re. lawsuits, etc. I think this is way overblown.....First of all, how many lawsuits have actually been filed against CXR...? How many government investigations is CXR the focus of....? As far as I can see (and someone please correct me if I'm wrong), the answer is zero. Those law firms making noise about suing CXR is just that - noise - until they actually file suit. Also, I suspect that, unlike say, a personal injury suit where a lawyer reviewing your case can tell in short order whether he can win money for you and thus offer you a "if we don't win, you don't pay any legal fees" deal, I think it's likley that if a CXR shareholder wants to be part of a suit, he/she will have to pony up a retainer fee with additional fees required after that depending on how far the suit progresses, all without any guarantee that they will receive one nickel in the end......contrast this with VRX who is facing actual lawsuits that have been filed agains the comlpany, criminal investigations by U.S. district attorneys' offices, etc., etc. re. the Philador online pharmacy issue etc., and in my view there is no comparison.....The real kicker here is, even with all these legal issues plus approximately $30 Billion of debt, VRX has been outperforming CXR over the past number of weeks.......simply doesn't make sense to me.....